179 related articles for article (PubMed ID: 6369502)
1. Plasma renin activity (PRA) and plasma aldosterone in the adrenal cortex hyperactivity. Studies on 50 hypertensive patients.
Augustin M; Dumitriu L; Ioaniţiu D; Popovici D; Gabrielescu-Berceanu A; Mănciulescu D; Marinescu I; Mazilu M; Dinulescu E; Tache A
Endocrinologie; 1984; 22(1):37-45. PubMed ID: 6369502
[TBL] [Abstract][Full Text] [Related]
2. The role of the renin-angiotensin system in arterial hypertension in hypercorticism.
Augustin M; Dumitriu L; Popovici D; Gabrielescu-Berceanu A; Ioaniţiu D; Mănciulescu D; Marinescu I; Tache A; Cristoveanu A; Pop A; Mazilu M; Stefănescu AM; Giurcăneanu M; Olaru A; Paţachi M; Ionescu V; Dinulescu E
Endocrinologie; 1983; 21(1):43-9. PubMed ID: 6342118
[TBL] [Abstract][Full Text] [Related]
3. [Adrenal gland carcinoma with mineralocorticoidism, increased plasma-renin activity and normal plasma aldosterone].
Rössler R; Klaus D; Klumpp F; Meyer D
Med Welt; 1973 Oct; 24(43):1644-7. PubMed ID: 4764058
[No Abstract] [Full Text] [Related]
4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
5. Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity.
Dall'Asta C; Vedani P; Manunta P; Pizzocri P; Marchi M; Paganelli M; Folli F; Pontiroli AE
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):110-4. PubMed ID: 18718746
[TBL] [Abstract][Full Text] [Related]
6. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
Chamontin B; Blanchouin-Emeric N; Amar J; Khatibi F; Vernier I; Bennet A; Aupetit-Faisant B; Salvador M
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378
[TBL] [Abstract][Full Text] [Related]
7. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
[TBL] [Abstract][Full Text] [Related]
8. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
Fardella CE; Montero J; Mosso L
Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
[TBL] [Abstract][Full Text] [Related]
9. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
Lifshits NL; Kutyrina IM
Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system in arterial hypertension.
Horký K; Gregorová I
Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
12. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
13. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
[TBL] [Abstract][Full Text] [Related]
14. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
16. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
van den Born BJ; Koopmans RP; van Montfrans GA
Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
[TBL] [Abstract][Full Text] [Related]
18. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
[TBL] [Abstract][Full Text] [Related]
20. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
